个人简历

1998 年毕业于第一军医大学临床医学系，2008年于中山大学肿瘤防治中心获医学博士学位。2008年-2012年于美国波士顿大学医学院免疫治疗中心从事博士后研究，主要开展乳腺癌肿瘤干细胞生物学研究、肿瘤干细胞/DC细胞融合疫苗免疫治疗研究等工作。2012年05月经中山大学\

研究领域

恶性肿瘤生物治疗、肿瘤干细胞/DC细胞融合疫苗研究

近期论文

1. Zhang HX, Jiang SS, Zhang XF, Zhou ZQ, Pan QZ, Chen CL, Zhao JJ, Tang Y, Xia JC, Weng DS(correpondence). Protein kinase CK2α catalytic subunit is overexpressed and serves asan unfavorable prognostic marker inprimary hepatocellular carcinoma. Oncotarget, 2015, 6(33):34800-34817. 2. Jiang SS, Weng DS（co-first author）, Wang QJ, Pan K, Zhang YJ, Li YQ, Li JJ, Zhao JJ, He J, Lv L, Pan QZ, Xia JC. Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma. J Transl Med., 12(1):273, 2014. 3. Wu Z*, Weng D(co-first author ), Li G. Quantitative proteome analysis of overexpressed Cripto-1 tumor cell reveals 14-3-3gamma as a novel biomarker in nasopharyngeal carcinoma. J Proteomics, 83C: 26-36, 2013 4. Weng D, Song B, Koido S, Calderwood SK, Gong J*. Immunotherapy of radioresistant mammary tumors with early metastasis using molecular chaperone vaccines combined with ionizing radiation. J Immunol, 191(2): 755-763, 2013 5. Weng D, Penzner JH, Song B, Koido S, Calderwood SK, Gong J*. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers. Breast Cancer Res., 14(1):R18, 2012 6. Weng D, Calderwood SK, Gong J*. Preparation of a heat-shock protein 70-based vaccine from DC-tumor fusion cells. Methods Mol Biol.,787:255-65, 2011 7. Weng D, Song B, Durfee J, Sugiyama V, Wu Z, Koido S, Calderwood SK, Gong J*. Induction of cytotoxic T lymphocytes against ovarian cancer-initiating cells. Int J Cancer., 129(8):1990-2001, 2011 8. Weng D, Cunin MC, Song B, Price BD, Eller MS, Gilchrest BA, Calderwood SK, Gong J*. Radiosensitization of mammary carcinoma cells by telomere homolog oligonucleotide pretreatment. Breast Cancer Res., 12(5):R71, 2010 9. Xia, JC*，Weng D. Progress of biotherapy in gastrointestinal carcinomas. Zhonghua Wei Chang Wai Ke Za Zhi 16(1): 22-27, 2013